// App-Quantinova.ai

Mo1280 : PROSPECTIVE MULTICENTRE RANDOMISED CONTROLLED TRIAL COMPARING THE SAFETY AND EFFECTIVENESS OF THE ENDOROTOR® MUCOSAL RESECTION DEVICE WITH CONTINUED ABLATION IN THE TREATMENT OF REFRACTORY BARRETT'S OESOPHAGUS: REPORT OF INITIAL OUTCOMES

Researchers

Presenter

  • Mohamed Hussein

Principal Investigators

  • Sarmed Sami

  • Laurence Lovat

  • Rehan Haidry

  • Kenneth K. Wang

Medical Centers

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Mayo Clinic, Rochester, Rochester, MN

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved